Capecitabine Combined With Lenvatinib and Tislelizumab as Adjuvant Treatment After Resection in Patients With BTC
Clinical trial NCT05254847 · COMPLETED
Trial details
- NCT number
- NCT05254847
- Sponsor
- Fudan University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2023-12-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.